DICE Therapeutics Inc. (DICE)
NASDAQ: DICE
· Real-Time Price · USD
47.55
0.03 (0.06%)
At close: Aug 08, 2023, 10:00 PM
DICE Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.13M | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.13M | n/a |
Operating Income | -39.5M | -31.57M | -26.45M | -21.17M | -21.74M | -18.86M | -16.21M | -16.13M | -7.17M | -8.09M |
Interest Income | 4.68M | 5.93M | 3.7M | 702K | 487K | 327K | 75K | 20K | 27K | 14K |
Pretax Income | -34.82M | -25.65M | -23.22M | -20.55M | -21.52M | -18.59M | -16.2M | -17.34M | -7.36M | -8.07M |
Net Income | -34.82M | -19.72M | -22.61M | -19.93M | -21.72M | -18.59M | -16.2M | -17.34M | -7.36M | -8.07M |
Selling & General & Admin | 11.3M | 7.91M | 6.36M | 6.44M | 7.41M | 5.45M | 4M | 4.44M | 2.32M | 1.47M |
Research & Development | 28.2M | 23.66M | 20.09M | 14.73M | 14.33M | 13.41M | 12.21M | 11.69M | 5.98M | 6.62M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 39.5M | 31.57M | 26.45M | 21.17M | 21.74M | 18.86M | 16.21M | 16.13M | 8.3M | 8.09M |
Interest Expense | n/a | n/a | 471K | 83K | 65K | 60K | 60K | 60K | 52K | 2K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 39.5M | 31.57M | 26.45M | 21.17M | 21.74M | 18.86M | 16.21M | 16.13M | 8.3M | 8.09M |
Income Tax Expense | n/a | -5.93M | -609K | -619K | 200K | n/a | -81K | 60K | 52K | 2K |
Shares Outstanding (Basic) | 47.31M | 47.19M | 45.43M | 37.48M | 37.36M | 37.26M | 37.16M | 7.55M | 34.32M | 23.23M |
Shares Outstanding (Diluted) | 47.31M | 47.19M | 45.43M | 37.48M | 37.36M | 37.26M | 37.16M | 7.55M | 34.32M | 23.23M |
EPS (Basic) | -0.74 | -0.42 | -0.5 | -0.53 | -0.58 | -0.5 | -0.44 | -2.3 | -0.21 | -0.35 |
EPS (Diluted) | -0.74 | -0.42 | -0.5 | -0.53 | -0.58 | -0.5 | -0.44 | -2.3 | -0.21 | -0.35 |
EBITDA | -34.13M | -25.65M | -22.75M | -19.87M | -20.56M | -18.01M | -16.14M | -15.97M | -6.97M | -7.89M |
EBIT | n/a | -31.57M | -22.75M | -20.47M | -21.46M | -18.53M | -16.14M | -17.27M | -7.29M | -8.08M |
Depreciation & Amortization | 687K | 5.93M | 3.7M | 1.3M | 1.19M | 519K | 156K | 146K | 179K | 180K |